Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
Virginie Siguret, Sébastian Voicu, Marie Neuwirth, Maxime Delrue, Étienne Gayat, Alain Stépanian, Bruno Mégarbane
Topics & Concepts
MedicineCritically illCoronavirus disease 2019 (COVID-19)AntibodyAnticardiolipin antibodies2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antiphospholipid syndromeImmunologyInternal medicineGastroenterologyVirologyDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSystemic Lupus Erythematosus ResearchDiabetes and associated disorders